Juliana Sartori
Universidade Federal do Rio Grande do Sul
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Juliana Sartori.
The International Journal of Neuropsychopharmacology | 2015
Gabriel Rodrigo Fries; Mirela Paiva Vasconcelos-Moreno; Carolina Gubert; Barbara T. Santos; Juliana Sartori; Bárbara Eisele; Pamela Ferrari; Adam Fijtman; Joëlle Rüegg; Nils C. Gassen; Flávio Kapczinski; Theo Rein; Marcia Kauer-Sant’Anna
Background: Impaired stress resilience and a dysfunctional hypothalamic-pituitary-adrenal (HPA) axis are suggested to play key roles in the pathophysiology of illness progression in bipolar disorder (BD), but the mechanisms leading to this dysfunction have never been elucidated. This study aimed to examine HPA axis activity and underlying molecular mechanisms in patients with BD and unaffected siblings of BD patients. Methods: Twenty-four euthymic patients with BD, 18 siblings of BD patients, and 26 healthy controls were recruited for this study. All subjects underwent a dexamethasone suppression test followed by analyses associated with the HPA axis and the glucocorticoid receptor (GR). Results: Patients with BD, particularly those at a late stage of illness, presented increased salivary post-dexamethasone cortisol levels when compared to controls (p = 0.015). Accordingly, these patients presented reduced ex vivo GR responsiveness (p = 0.008) and increased basal protein levels of FK506-binding protein 51 (FKBP51, p = 0.012), a co-chaperone known to desensitize GR, in peripheral blood mononuclear cells. Moreover, BD patients presented increased methylation at the FK506-binding protein 5 (FKBP5) gene. BD siblings presented significantly lower FKBP51 protein levels than BD patients, even though no differences were found in FKBP5 basal mRNA levels. Conclusions: Our data suggest that the epigenetic modulation of the FKBP5 gene, along with increased FKBP51 levels, is associated with the GR hyporesponsiveness seen in BD patients. Our findings are consistent with the notion that unaffected first-degree relatives of BD patients share biological factors that influence the disorder, and that such changes are more pronounced in the late stages of the illness.
Journal of Affective Disorders | 2014
Gabriel Rodrigo Fries; Mirela Paiva Vasconcelos-Moreno; Carolina Gubert; Barbara T. Santos; André Luiz Schuh Teixeira da Rosa; Bárbara Eisele; Juliana Sartori; Bianca Pfaffenseller; Flávio Kapczinski; Marcia Kauer-Sant’Anna
BACKGROUND The pathophysiology of bipolar disorder (BD) includes several systemic alterations, such as inflammatory markers, oxidative stress, and DNA damage. Most of these parameters may be related to dysfunctions in cellular resilience mechanisms reported in patients, such as endoplasmic reticulum stress and mitochondrial damage. As a consequence, these impairments can ultimately lead to cell death. Therefore, the aim of this study was to assess cell death and viability in peripheral blood mononuclear cells (PBMCs) from patients with BD and controls. METHODS Ten euthymic patients with BD type I and seven age- and sex-matched healthy controls were recruited and had peripheral blood collected by venipuncture in heparine tubes. PBMCs were isolated from total blood, followed by measurement of cell viability by trypan blue exclusion, and apoptosis and necrosis by anexin V/propidium iodide (PI) staining. RESULTS Cell viability did not significantly differ between groups, as well as the percentage of cells in necrosis or in late apoptosis/necrosis. However, the percentage of cells in early apoptosis was higher in patients when compared with controls (p=0.002). LIMITATIONS This is a preliminary study with relatively small sample size. CONCLUSIONS The systemic toxicity along with dysfunctional cell resilience mechanisms reported in patients with BD may be inducing apoptosis in PBMCs. A deeper look into the clinical relevance of such findings is warranted.
Jornal Brasileiro De Pneumologia | 2013
Renato Seligman; Luis Francisco Ramos-Lima; Vivian do Amaral Oliveira; Carina Tôrres Sanvicente; Juliana Sartori; Elyara Fiorin Pacheco
OBJECTIVE: To identify risk factors for the development of hospital-acquired pneumonia (HAP) caused by multidrug-resistant (MDR) bacteria in non-ventilated patients. METHODS: This was a retrospective observational cohort study conducted over a three-year period at a tertiary-care teaching hospital. We included only non-ventilated patients diagnosed with HAP and presenting with positive bacterial cultures. Categorical variables were compared with chi-square test. Logistic regression analysis was used to determine risk factors for HAP caused by MDR bacteria. RESULTS: Of the 140 patients diagnosed with HAP, 59 (42.1%) were infected with MDR strains. Among the patients infected with methicillin-resistant Staphylococcus aureus and those infected with methicillin-susceptible S. aureus, mortality was 45.9% and 50.0%, respectively (p = 0.763). Among the patients infected with MDR and those infected with non-MDR gram-negative bacilli, mortality was 45.8% and 38.3%, respectively (p = 0.527). Univariate analysis identified the following risk factors for infection with MDR bacteria: COPD; congestive heart failure; chronic renal failure; dialysis; urinary catheterization; extrapulmonary infection; and use of antimicrobial therapy within the last 10 days before the diagnosis of HAP. Multivariate analysis showed that the use of antibiotics within the last 10 days before the diagnosis of HAP was the only independent predictor of infection with MDR bacteria (OR = 3.45; 95% CI: 1.56-7.61; p = 0.002). CONCLUSIONS: In this single-center study, the use of broad-spectrum antibiotics within the last 10 days before the diagnosis of HAP was the only independent predictor of infection with MDR bacteria in non-ventilated patients with HAP.
The International Journal of Neuropsychopharmacology | 2017
Mirela Paiva Vasconcelos-Moreno; Gabriel Rodrigo Fries; Carolina Gubert; Barbara T. Santos; Adam Fijtman; Juliana Sartori; Pamela Ferrari; Lucas Kich Grun; Mariana Migliorini Parisi; Fátima Theresinha Costa Rodrigues Guma; Florencia María Barbé-Tuana; Flávio Kapczinski; Adriane Ribeiro Rosa; Lakshmi N. Yatham; Marcia Kauer-Sant’Anna
Abstract Background: Growing evidence supports the existence of neurobiological trait abnormalities in individuals at genetic risk for bipolar disorder. The aim of this study was to examine potential differences in brain-derived neurotrophic factor, cytokines, oxidative stress, and telomere length markers between patients with bipolar disorder, their siblings, and healthy controls. Methods: Thirty-six patients with bipolar disorder type I, 39 siblings, and 44 healthy controls were assessed. Serum levels of brain-derived neurotrophic factor, interleukin-6, interleukin-10, tumor necrosis factor-α, C-C motif chemokine 11, C-C motif chemokine 24, and 3-nitrotyrosine were measured, as were the activities of glutathione peroxidase, glutathione reductase, and glutathione S-transferase. Telomere length (T/S ratio) was measured using quantitative polymerase chain reaction. Results: Telomere length was different between the 3 groups (P = .041) with both patients and siblings showing a shorter T/S ratio compared with healthy controls. Patients showed increased levels of interleukin-6 (P = .005) and interleukin-10 (P = .002) compared with controls as well as increased levels of interleukin-6 (p = 0.014) and CCL24 (P = .016) compared with their siblings. C-C motif chemokine 11 levels were increased in siblings compared with controls (P = .015), and a similar tendency was found in patients compared with controls (P = .045). Glutathione peroxidase activity was decreased in patients compared with controls (P = .006) and siblings (P = .025). No differences were found for the other markers. Conclusions: The present results suggest that unaffected siblings may present accelerated aging features. These neurobiological findings may be considered as endophenotypic traits. Further prospective studies are warranted.
Journal of Psychiatric Research | 2018
Juliana Sartori; Ramiro de Freitas Xavier Reckziegel; Ives Cavalcante Passos; Letícia Sanguinetti Czepielewski; Adam Fijtman; Leonardo de Almeida Sodré; Raffael Massuda; Pedro Domingues Goi; Mireia Vianna-Sulzbach; Taiane de Azevedo Cardoso; Flavio Kapczinski; Benson Mwangi; Clarissa Severino Gama
Neuroimaging studies have been steadily explored in Bipolar Disorder (BD) in the last decades. Neuroanatomical changes tend to be more pronounced in patients with repeated episodes. Although the role of such changes in cognition and memory is well established, daily-life functioning impairments bulge among the consequences of the proposed progression. The objective of this study was to analyze MRI volumetric modifications in BD and healthy controls (HC) as possible predictors of daily-life functioning through a machine learning approach. Ninety-four participants (35 DSM-IV BD type I and 59 HC) underwent clinical and functioning assessments, and structural MRI. Functioning was assessed using the Functioning Assessment Short Test (FAST). The machine learning analysis was used to identify possible candidates of regional brain volumes that could predict functioning status, through a support vector regression algorithm. Patients with BD and HC did not differ in age, education and marital status. There were significant differences between groups in gender, BMI, FAST score, and employment status. There was significant correlation between observed and predicted FAST score for patients with BD, but not for controls. According to the model, the brain structures volumes that could predict FAST scores were: left superior frontal cortex, left rostral medial frontal cortex, right white matter total volume and right lateral ventricle volume. The machine learning approach demonstrated that brain volume changes in MRI were predictors of FAST score in patients with BD and could identify specific brain areas related to functioning impairment.
Psychiatry Research-neuroimaging | 2016
Carolina Gubert; Cesar Eduardo Jacintho Moritz; Mirela Paiva Vasconcelos-Moreno; Barbara T. Santos; Juliana Sartori; Adam Fijtman; Marcia Kauer-Sant’Anna; Flávio Kapczinski; Ana Maria Oliveira Battastini; Pedro Vieira da Silva Magalhães
Archive | 2017
Lucas Mohr Patusco; Carolina Gubert; Cesar Eduardo Jacintho Moritz; Mirela Paiva Vasconcelos Moreno; Juliana Sartori; Adam Fijtman; Marcia Kauer-Sant’Anna; Flávio Pereira Kapczinski; Ana Maria Oliveira Battastini; Pedro Vieira da Silva Magalhães
Schizophrenia Research | 2014
Clarissa Severino Gama; Letícia Sanguinetti Czepielewski; Mariana Pedrini; Juliana Sartori; Marina Dalla Barba Londero; Sandra Raquel Lermen Polita; Juliana Ávila Duarte; Pedro Domingues Goi; Mireia Vianna-Sulzbach; Paulo Silva Belmonte-de-Abreu; Raffael Massuda
Archive | 2014
Mirela Paiva Vasconcelos-Moreno; Gabriel R. Fries; Carolina Gubert; Barbara T. Santos; Pamela Ferrari; Kelen P. Burke; Juliana Sartori; Raffael Massuda; Clarissa Severino Gama; Flávio Pereira Kapczinski; Theo Rein; Márcia Kauer-Sant'Anna
Archive | 2014
Monise Costanzi; Letícia Sanguinetti Czepielewski; Mariana Pedrini; Juliana Sartori; Marina Dalla Barba Londero; Sandra Raquel Lermen Polita; Juliana Ávila Duarte; Pedro Domingues Goi; Miréia Fortes Vianna Sulzbach; Clarissa Severino Gama
Collaboration
Dive into the Juliana Sartori's collaboration.
Luciane Maria Fabian Restelatto
Universidade Federal do Rio Grande do Sul
View shared research outputs